360 related articles for article (PubMed ID: 27085785)
1. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC
Metabolism; 2016 May; 65(5):783-793. PubMed ID: 27085785
[TBL] [Abstract][Full Text] [Related]
2. Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Williams KH; Sullivan DR; Veillard AS; O'Brien R; George J; Jenkins AJ; Young S; Ehnholm C; Duffield A; Twigg SM; Keech AC
Diabet Med; 2016 Mar; 33(3):356-64. PubMed ID: 26433207
[TBL] [Abstract][Full Text] [Related]
3. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
5. Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38).
Deetman PE; Alkhalaf A; Landman GW; Groenier KH; Kootstra-Ros JE; Navis G; Bilo HJ; Kleefstra N; Bakker SJ
Eur J Clin Invest; 2015 Aug; 45(8):807-14. PubMed ID: 26046667
[TBL] [Abstract][Full Text] [Related]
6. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
7. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults.
Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR
Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318
[TBL] [Abstract][Full Text] [Related]
8. Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins.
Fraser A; Thinggaard M; Christensen K; Lawlor DA
Liver Int; 2009 Nov; 29(10):1494-9. PubMed ID: 19686309
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
Scott R; Best J; Forder P; Taskinen MR; Simes J; Barter P; Keech A;
Cardiovasc Diabetol; 2005 Aug; 4():13. PubMed ID: 16111499
[TBL] [Abstract][Full Text] [Related]
10. Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with risk of mortality by age.
Oh CM; Won YJ; Cho H; Lee JK; Park BY; Jun JK; Koh DH; Ki M; Jung KW; Oh IH
Liver Int; 2016 Jan; 36(1):126-35. PubMed ID: 26036985
[TBL] [Abstract][Full Text] [Related]
11. Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2019 May; 10(3):837-845. PubMed ID: 30204299
[TBL] [Abstract][Full Text] [Related]
12. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
Wannamethee SG; Shaper AG; Lennon L; Whincup PH
Diabetes Care; 2005 Dec; 28(12):2913-8. PubMed ID: 16306554
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
[TBL] [Abstract][Full Text] [Related]
14. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
[TBL] [Abstract][Full Text] [Related]
15. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
Newsome P; Francque S; Harrison S; Ratziu V; Van Gaal L; Calanna S; Hansen M; Linder M; Sanyal A
Aliment Pharmacol Ther; 2019 Jul; 50(2):193-203. PubMed ID: 31246368
[TBL] [Abstract][Full Text] [Related]
16. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Keech A; Simes RJ; Barter P; Best J; Scott R; Taskinen MR; Forder P; Pillai A; Davis T; Glasziou P; Drury P; Kesäniemi YA; Sullivan D; Hunt D; Colman P; d'Emden M; Whiting M; Ehnholm C; Laakso M;
Lancet; 2005 Nov; 366(9500):1849-61. PubMed ID: 16310551
[TBL] [Abstract][Full Text] [Related]
18. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study.
Nguyen QM; Srinivasan SR; Xu JH; Chen W; Hassig S; Rice J; Berenson GS
Diabetes Care; 2011 Dec; 34(12):2603-7. PubMed ID: 21953798
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
Unalp-Arida A; Ruhl CE
Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
